Verified Nov 2026
Batteries & E-Mobility
·

Wuxi, Jiangsu
·
Since 2010
WuXi Biologics is a contract research, development, and manufacturing organization headquartered in Wuxi, Jiangsu, China, founded in 2010. The company employs 10,000–50,000 staff and generates an estimated $1–5 billion in annual revenue. It serves the pharmaceutical, biotech, automotive, and medical device industries, offering biologics drug discovery, cell line development, and commercial manufacturing. In 2026, the company completed expansion of a drug product facility in Singapore.
WuXi Biologics at a glance
Revenue
$1-5B
Est. band
Employees
10,000-50,000
Founded
2010
Headquarters
Wuxi, Jiangsu
Certifications
ISO 13485 · ISO 14001 · ISO 45001
Import activity
7
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
7
Named foreign suppliers
7
Top origins
China · Canada · Ireland · Spain

Shared foreign counterparties do not establish that these companies buy from WuXi Biologics.
What this tells a buyer
The company received 7 tracked shipments from suppliers across China, Canada, Ireland, and Spain, with volume originating from a biomedical equipment provider in China.
WuXi Biologics holds ISO 13485, ISO 14001, and ISO 45001 certifications and operates 18 manufacturing sites globally, providing end-to-end vaccine development, monoclonal antibody manufacturing, protein production, and continuous manufacturing services.
The company entered an exclusive development agreement with Fresenius in 2026 to expand its biosimilars pipeline and collaborated with Earendil Labs to advance bispecific and multispecific antibody manufacturing.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
16 years in operation (founded 2010).
7 US import shipments on record.
Holds ISO 13485, ISO 14001, ISO 45001 certification(s) per public sources.
Overview
WuXi Biologics is a contract research, development, and manufacturing organization headquartered in Wuxi, Jiangsu, China, founded in 2010. The company employs 10,000–50,000 staff and generates an estimated $1–5 billion in annual revenue. It serves the pharmaceutical, biotech, automotive, and medical device industries, offering biologics drug discovery, cell line development, and commercial manufacturing. In 2026, the company completed expansion of a drug product facility in Singapore.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Wuxi, Jiangsu |
Employees | 10,000-50,000 |
Revenue | $1-5B (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 13485 · ISO 14001 · ISO 45001 |
What WuXi Biologics makes
WuXi Biologics holds ISO 13485, ISO 14001, and ISO 45001 certifications and operates 18 manufacturing sites globally, providing end-to-end vaccine development, monoclonal antibody manufacturing, protein production, and continuous manufacturing services.
Certifications
WuXi Biologics is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — wuxibiologics.com
ISO 14001 — wuxibiologics.com
ISO 45001 — wuxibiologics.com
Trade and customs footprint
The company received 7 tracked shipments from suppliers across China, Canada, Ireland, and Spain, with volume originating from a biomedical equipment provider in China. US customs bill-of-lading records list 7 inbound shipments across 7 foreign suppliers, with top origins including China · Canada · Ireland · Spain.
Latest developments
2026-11-02 — Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline | FSE (fresenius.com)
2026-08-25 — WuXi Biologics Reports Strong Profitable Growth in H1 2026 (wuxibiologics.com)
2026-06-05 — WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility (wuxibiologics.com)
2026-03-24 — WuXi Biologics Reports Record 2025 Annual Results (wuxibiologics.com)
2026-03-12 — WuXi Biologics and Earendil Labs Enter Strategic Collaboration to Accelerate Development and Manufacturing of Bispecific/Multispecific Antibodies and ADCs (wuxibiologics.com)
2026-02-03 — WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager (wuxibiologics.com)
Facilities
WuXi Biologics is headquartered in Wuxi, Jiangsu. Public sources also reference these locations:
Tuas, Singapore — wuxibiologics.com
Company details
The company entered an exclusive development agreement with Fresenius in 2026 to expand its biosimilars pipeline and collaborated with Earendil Labs to advance bispecific and multispecific antibody manufacturing. WuXi Biologics was founded in 2010, has an estimated 10,000-50,000 employees, and is headquartered in Wuxi, Jiangsu. On the LightSource stability read it is rated "Established & active": 16 years in operation (founded 2010). 7 US import shipments on record. Holds ISO 13485, ISO 14001, ISO 45001 certification(s) per public sources.
Frequently asked questions
What does WuXi Biologics make?
WuXi Biologics is a contract research, development, and manufacturing organization headquartered in Wuxi, Jiangsu, China, founded in 2010. The company employs 10,000–50,000 staff and generates an estimated $1–5 billion in annual revenue. It serves the pharmaceutical, biotech, automotive, and medical device industries, offering biologics drug discovery, cell line development, and commercial manufacturing. In 2026, the company completed expansion of a drug product facility in Singapore.
Where is WuXi Biologics headquartered?
WuXi Biologics is headquartered in Wuxi, Jiangsu.
When was WuXi Biologics founded?
WuXi Biologics was founded in 2010.
How big is WuXi Biologics?
WuXi Biologics has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).
What certifications does WuXi Biologics hold?
WuXi Biologics lists ISO 13485 · ISO 14001 · ISO 45001 on its website. Confirm the certified scope for the specific plant producing your part.
Does WuXi Biologics import from overseas suppliers?
US customs bill-of-lading records show 7 inbound shipments for WuXi Biologics, with top origins including China · Canada · Ireland · Spain.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
'+86 510 8183 1205
Certification
ISO 13485 · ISO 14001 · ISO 45001
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
